Amgen (AMGN)

$270.86 2.69 (0.98%)

9:34 EDT AMGN Stock Quote Delayed 30 Minutes

The Dividend Goldmine: 3 Shining Stocks With Growing Payouts

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 19, 2024

Explore opportunities in the cable, restaurant and biotechnology sectors, revealing how dividend growth stocks are maximizing returns.

Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble

Coming FDA Approvals Could Send These 3 Drug Stocks Soaring

The 3 Best Biotech Stocks to Buy Now: Q2 Edition

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 77,058

Day's Range $270.05 - $271.00

52-Week Range $218.44 - $329.72

Dividend & Yield $8.52 (3.15%)

AMGN Stock Predictions, Articles, and Amgen News

From InvestorPlace
From the Web

3 Stocks to Buy Low Today With High Hopes for Tomorrow

By Stavros Tousios, InvestorPlace Contributor Apr 15, 2024

Amgen, Canadian Solar, and Diana Shipping are three undervalued stocks with high potential for growth that can enhance portfolio returns.

3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April

By Chris MacDonald, InvestorPlace Contributor Apr 9, 2024

These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term.

The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024

By Michael Que, InvestorPlace Contributor Apr 7, 2024

Our economy is on the up and up, and investing is a must,. Let's review the most undervalued S&P 500 stocks to buy in April.

3 Biotech Stocks to Buy on the Dip: March 2024

By Ian Cooper, InvestorPlace Contributor Mar 27, 2024

Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.

Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating

By Rich Duprey, InvestorPlace Contributor Mar 25, 2024

Warren Buffett stocks and Berkshire Hathaway's portfolio of companies are hidden investment vehicles hiding in plain sight.

Hot Stocks: The 3 Best Opportunities for Investing in Biotech

By Chandler Capital, InvestorPlace Contributor Mar 21, 2024

Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now.

Hot Stocks: The 3 Best Opportunities for Investing in the Dow

By Josh Enomoto, InvestorPlace Contributor Mar 20, 2024

While investing in Dow stocks – that is, the 30 companies making up the Dow Jones Industrial Average – might seem incredibly boring, investors shouldn’t…

Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks

By Josh Enomoto, InvestorPlace Contributor Mar 10, 2024

The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market. According to a Goldman Sachs analysis, earlier last…

It’s Time! 3 Dodgy Pharma Stocks to Sell in February

By Shane Neagle, InvestorPlace Contributor Mar 4, 2024

Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action.

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

By Josh Enomoto, InvestorPlace Contributor Feb 15, 2024

Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor Feb 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

3 Fantastic Dow Stocks to Buy in February 2024

By Rich Duprey, InvestorPlace Contributor Feb 5, 2024

The venerable index is more representative of today's economy and these three Dow stocks to buy are brightly shining component stars.

Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs

By Larry Ramer, InvestorPlace Contributor Jan 25, 2024

The best weight-loss drug stocks are improving the drugs or developing new, potentially superior, weight-loss treatments.

Dogs of the Dow: January’s Top 3 Picks to Buy for Big Gains

By Larry Ramer, InvestorPlace Contributor Jan 10, 2024

Buying Dogs of the Dow stocks is an attractive strategy that involves buying stocks with high dividend yields that have often underperformed.

Why Is Xeris Biopharma (XERS) Stock Up 12% Today?

By William White, InvestorPlace Writer Jan 10, 2024

Xeris Biopharma stock is rising higher on Wednesday as investors in XERS shares react to a new exclusive worldwide license agreement.

3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’

By TradeSmith Research Staff Dec 21, 2023

It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone."

Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts

By Chris MacDonald, InvestorPlace Contributor Oct 24, 2023

Investors appear to be viewing Amgen's recent job cuts as a positive today, with buying pressure resulting in a 1% move higher in AMGN stock.

3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals

By Larry Ramer, InvestorPlace Contributor Sep 28, 2023

The demand for obesity drugs is intense and is likely to only greatly increase going forward, since over 40% of Americans were obese in 2020.

The 3 Most Undervalued Biotech Stocks to Buy in September 2023

By Joel Baglole, InvestorPlace Contributor Sep 12, 2023

While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.

These Are the ONLY 3 Biotech Stocks to Consider in August 2023

By Muslim Farooque, InvestorPlace Contributor Aug 21, 2023

These biotech stocks to buy represent tremendous bets and are essentially fueling innovation and portfolio growth at the same time.

Amgen (AMGN)

The Dividend Goldmine: 3 Shining Stocks With Growing Payouts

Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble

Coming FDA Approvals Could Send These 3 Drug Stocks Soaring

The 3 Best Biotech Stocks to Buy Now: Q2 Edition

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Amgen (AMGN)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AMGN Stock Predictions, Articles, and Amgen News

Subscriber Sign in